Bespoke Extracts (BSPK) Current Assets (2011 - 2025)
Bespoke Extracts (BSPK) reported Current Assets of $196832.0 for Q3 2025, up 58.67% on a YoY basis from $124050.0 in Q3 2024, and up 27.21% sequentially from $154736.0 in Q2 2025.
Bespoke Extracts (BSPK) Current Assets (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Current Assets data on file, last reported at $196832.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Assets rose 58.67% year-over-year to $196832.0; the trailing twelve-month figure through Sep 2025 stood at $196832.0 (up 58.67% YoY), and the FY2024 full-year result was $165257.0, up 101.93% from the prior year.
- Current Assets grew to $196832.0 in Q3 2025, from $154736.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $609406.0 in Q1 2021 to a low of $54023.0 in Q3 2022.
- A 5-year average of $152765.4 and a median of $124050.0 in 2024 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 1437.96% in 2021, while the deepest fall reached 78.52% in 2021.
- Tracing BSPK's Current Assets over 5 years: stood at $64361.0 in 2021, then jumped by 73.6% to $111732.0 in 2022, then retreated by 26.75% to $81839.0 in 2023, then surged by 101.93% to $165257.0 in 2024, then climbed by 19.11% to $196832.0 in 2025.
- Business Quant data shows BSPK's Current Assets at $196832.0 in Q3 2025, $154736.0 in Q2 2025, and $123120.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 196,832.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 196,832.00 |
| Jun 30, 2025 | 154,736.00 |
| Mar 31, 2025 | 123,120.00 |
| Dec 31, 2024 | 165,257.00 |
| Sep 30, 2024 | 124,050.00 |
| Jun 30, 2024 | 133,549.00 |
| Mar 31, 2024 | 103,771.00 |
| Dec 31, 2023 | 81,839.00 |
| Sep 30, 2023 | 96,964.00 |
| Jun 30, 2023 | 137,851.00 |
| Mar 31, 2023 | 148,783.00 |
| Dec 31, 2022 | 111,732.00 |
| Sep 30, 2022 | 54,023.00 |
| Jun 30, 2022 | 73,820.00 |
| Mar 31, 2022 | 176,568.00 |
| Nov 30, 2021 | 64,361.00 |
| Aug 31, 2021 | 89,027.00 |
| May 31, 2021 | 256,854.00 |
| Feb 28, 2021 | 609,406.00 |
| Nov 30, 2020 | 299,572.00 |